« Previous Next » Lung Cancer
Volume 70, Issue 1 , Pages 63-70 , October 2010

The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis

Sufeng Chen
- Department of Cardiothoracic Surgery, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 600 Yishan Road, Shanghai 200233, People's Republic of China
- These two authors contributed equally to this paper.
Jie Zhang
- Department of Thoracic Surgery, Cancer Hospital of Fudan University, 399 Ling Lin Street, Shanghai 200032, People's Republic of China
- These two authors contributed equally to this paper.
Rui Wang
- Department of Thoracic Surgery, Cancer Hospital of Fudan University, 399 Ling Lin Street, Shanghai 200032, People's Republic of China
Xiaoyang Luo
- Department of Thoracic Surgery, Cancer Hospital of Fudan University, 399 Ling Lin Street, Shanghai 200032, People's Republic of China
Haiquan Chen
- Department of Cardiothoracic Surgery, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 600 Yishan Road, Shanghai 200233, People's Republic of China
- Department of Thoracic Surgery, Cancer Hospital of Fudan University, 399 Ling Lin Street, Shanghai 200032, People's Republic of China
- Corresponding author at: Department of Thoracic Surgery, Cancer Hospital of Fudan University, 399 Ling Lin Street, Shanghai 200032, People's Republic of China. Tel.: +86 136 0197 3588; fax: +86 21 5635 3642.